Klariger (Clarithromycin)

Clarithromycin binds to the 50S ribosomal subunit of susceptible bacteria, blocking the translocation step of protein synthesis. This inhibition halts peptide chain elongation, resulting in a bacteriostatic effect that limits bacterial growth and allows the immune system to clear the infection.

The dosage of Klariger is determined by the prescribing clinician based on the specific infection, patient weight, renal and hepatic function, and local treatment guidelines. Patients should follow the exact regimen provided by their healthcare professional.

Safety data for clarithromycin in pregnancy and lactation are limited. The drug should only be used if the potential benefit justifies any possible risk to the fetus or infant, and the decision must be made by a qualified prescriber.

To request Klariger, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and the necessary import documentation.

Clarithromycin generally offers a broader spectrum against certain Gram‑positive organisms and better activity against atypical pathogens compared with azithromycin. It also has a longer half‑life, allowing twice‑daily dosing, whereas azithromycin often permits once‑daily dosing but may have a different side‑effect profile.

Klariger should be stored at room temperature below 25 °C. Keep the tablets in the original packaging, protect them from moisture and direct sunlight, and ensure they are kept out of reach of children.

Klariger is taken orally, usually with a full glass of water. It can be taken with or without food, but taking it with meals may reduce gastrointestinal upset. The exact schedule (e.g., twice daily) is set by the prescribing clinician.

Serious risks include severe allergic reactions such as anaphylaxis, QT interval prolongation that can lead to cardiac arrhythmias, and Clostridioides difficile‑associated colitis. Patients should seek immediate medical attention if they experience rash, palpitations, dizziness, or persistent diarrhea.

Klariger should be avoided in individuals with known hypersensitivity to clarithromycin or other macrolides, in patients with severe hepatic impairment, and in those taking medications that have contraindicated interactions, such as cisapride or ergot alkaloids. Pregnant or breastfeeding women should use it only if clearly indicated by a healthcare professional.